Capricor Therapeutics Correlations
| CAPR Stock | USD 13.28 0.42 3.27% |
The current 90-days correlation between Capricor Therapeutics and AnaptysBio is -0.02 (i.e., Good diversification). The correlation of Capricor Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Capricor Therapeutics Correlation With Market
Modest diversification
The correlation between Capricor Therapeutics and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Capricor |
Moving together with Capricor Stock
Moving against Capricor Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Capricor Stock performing well and Capricor Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Capricor Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BPTH | 8.68 | (0.53) | 0.00 | (35.50) | 0.00 | 15.63 | 189.05 | |||
| CBIO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| DFFN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NXTC | 3.55 | (0.60) | 0.00 | (0.35) | 0.00 | 6.74 | 21.57 | |||
| PULM | 4.54 | 0.47 | 0.09 | 0.72 | 4.85 | 9.74 | 41.84 | |||
| AKTX | 5.25 | 0.85 | 0.15 | 1.16 | 5.30 | 18.18 | 41.26 | |||
| SLNO | 2.26 | 0.22 | 0.10 | (0.87) | 2.42 | 4.99 | 20.36 | |||
| UNCY | 3.93 | 0.01 | 0.00 | (0.02) | 0.00 | 7.69 | 28.72 | |||
| CDTX | 3.27 | 0.11 | 0.03 | 0.76 | 5.15 | 6.59 | 19.84 | |||
| PHIO | 11.03 | 1.87 | 0.16 | 0.44 | 9.59 | 9.40 | 336.29 |
Capricor Therapeutics Corporate Management
| JD Esq | General VP | Profile | |
| Deborah Ascheim | Chief Medical Officer | Profile | |
| Kristi Elliott | Chief Officer | Profile | |
| Xavier Avat | Chief Officer | Profile | |
| MD FACC | Executive Board | Profile | |
| Minghao Sun | Senior Development | Profile |